Abstract
Among patients with methicillin-resistant Staphylococcus aureus (MRSA) bacteremia from a prospective randomized clinical trial, acute kidney injury (AKI) rates increased with increasing vancomycin exposure, even within the therapeutic range. AKI was independently more common for the (flu)cloxacillin group. Day 2 vancomycin AUC ≥470 mg·h/L was significantly associated with AKI, independent of (flu)cloxacillin receipt.
Original language | English |
---|---|
Article number | ofaa538 |
Pages (from-to) | 1-5 |
Number of pages | 5 |
Journal | Open Forum Infectious Diseases |
Volume | 7 |
Issue number | 12 |
Early online date | Nov 2020 |
DOIs | |
Publication status | Published - Dec 2020 |
Bibliographical note
Publisher Copyright:© 2020 The Author(s). Published by Oxford University Press on behalf of Infectious Diseases Society of America.
Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.